Northstar Biotech and USRM BOD Members Reinvest in the Company
SUNRISE, FL – Feb 23, 2021 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce…
USRM Oral Argument in Appeal from FDA Enforcement Action
SUNRISE, FL – Jan 19, 2021 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce…
U.S. Stem Cell Confirms Date for Appeals Court Oral Arguments
SUNRISE, FL – Sep. 30, 2020 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce…
CEO Blog: A Summary of Recent Events
Dear Shareholders and Friends, Thank you for your continued interest and support in U.S. Stem Cell, Inc. In an effort to keep you updated on matters related to the Company,…
Corrected: USRM Posts Earnings for Second Quarter 2019
SUNRISE, FL – August 7, 2019 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Posts Earnings for Second Quarter 2019
SUNRISE, FL – August 7, 2019 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Posts Financial Results for First Quarter 2019
SUNRISE, FL – May 7, 2019 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Posts Increase in Revenue and Profit Margin for 2018
SUNRISE, FL – March 13, 2019 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM Chief Science Officer Featured on One Radio Network
SUNRISE, FL – January 15, 2019 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
USRM announces U.S. Stem Cell Clinic Expansion of Products and Services
Increasing Market Demand for Regenerative Therapies Drives Diversification SUNRISE, FL – December 06, 2018 – U.S. Stem Cell Inc, a leader in regenerative medicine products and services, today announced its…
Dr. Kristin Comella Featured on Robert Scott Bell Show
USRM Chief Science Officer Discusses Health Freedom Surrounding Autologous Stem Cell Industry SUNRISE, FL – November 9, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development…
USRM Posts 25% Nine Month Revenue Increase From 3Q 2017
Profit Margins Continue to Increase As Costs And Operating Expenses Decrease SUNRISE, FL – November 06, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of…